Cidara Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Cidara Therapeutics stock have a consensus rating of "Buy" and an average price target of $119.44, which forecasts a -45.65% decrease in the stock price over the next year. The lowest target is $35 and the highest is $200.

Price Target: $119.44 (-45.65%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$35	$119.44	$145	$200
Change	-84.07%	-45.65%	-34.02%	-8.99%

Analyst Ratings

The average analyst rating for Cidara Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	6	6	7	7	7	4
Buy	5	5	5	4	6	6
Hold	0	0	0	0	0	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	12	11	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Seamus Fernandez Guggenheim	Guggenheim	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 18, 2025
Joseph Stringer Needham	Needham	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 14, 2025
Sara Nik HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 14, 2025
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $137 → $145	Buy	Maintains	$137 → $145	-34.02%	Nov 7, 2025
Joseph Stringer Needham	Needham	Strong Buy Maintains $100 → $135	Strong Buy	Maintains	$100 → $135	-38.57%	Nov 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.28M

Revenue Next Year

7.50M

EPS This Year

-6.13

from -26.75

EPS Next Year

-7.96

from -6.13

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	12.07M	49.57M	23.50M	23.28M	1.28M	-	7.50M
Revenue Growth	-42.31%	310.81%	-52.60%	-0.91%	-94.52%	-	-
EPS	-36.03	-16.20	-9.61	-5.25	-26.75	-6.13	-7.96
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	30.5M
Avg	n/a	7.5M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-4.20	-4.10
Avg	-6.13	-7.96
Low	-7.04	-13.28

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.